Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Crown Bioscience has announced the strengthening of its global Immuno-Oncology Platform at all its key facilities in Europe, USA, and Asia to support client’s needs with a comprehensive collection of validated models and services for in vivo ...
read more
WIRB-Copernicus Group®, a provider of solutions that measurably improve the quality and efficiency of clinical research, has announced its acquisition of CenterWatch, a provider of clinical trial industry news and information, and the addition of ...
read more
MedAvante a provider of technology-based clinical trial services for central nervous system (CNS) diseases, announced two new members of its Board of Directors: Richard F. Cimino, former Covance, Inc. EVP and Group President of Clinical Development ...
read more
DHL has recognized the performance of four major air cargo carriers with the first DHL Carrier Award for Reliability and Excellence, DHL CARE Award, which sets a new industry standard for reliability and quality for air-freight transport of ...
read more
Pfizer has completed its acquisition of Anacor Pharmaceuticals, Inc. Under the terms of the transaction, each outstanding share of Anacor common stock has been converted into the right to receive $99.25 net in cash (without interest but subject to ...
read more
Mylan has announced the U.S. launch of Dutasteride Capsules, 0.5 mg, the generic version of GlaxoSmithKline's Avodart® Capsules.
read more
HealthCore, Inc. will collaborate with PCORnet, the National Patient-Centered Clinical Research Network, on building a sustainable patient-centered outcomes research network to conduct real-world comparative effectiveness research as part of a ...
read more
Quintiles has announced the launch of its new Continuous Glucose Monitoring (CGM) service offering. This new solution combines innovative, wearable technology with Quintiles’ deep therapeutic and analytical expertise to help enhance the efficiency ...
read more
Teewinot Life Sciences Corporation and Albany Molecular Research, Inc. (AMRI) have announced that AMRI licensed Teewinot's technology to produce and sell the first commercially available cannabichromene acid (CBCA) analytical standard. The CBCA ...
read more
Veeva Systems and Kinapse Ltd., a provider of life sciences advisory and operational services, announced that Kinapse has selected Veeva Vault Submissions to power its new regulatory operational services.
read more
Pharm-Olam International Ltd., a multinational, full-service Clinical Research Organization (CRO), serving the biopharmaceutical and medical device industries, announces the appointment of Fabiola Encinas as the Country Operations Manager for Mexico.
read more
BlueTheory Clinical Trials, a clinical research network company headquartered in Boston, Massachusetts has been partnering with pharmaceutical and contract research organizations (CROs) to bring treatments and devices to the market since its ...
read more
MEDIAN Technologies, a medical imaging software developer and service provider for image interpretation and management in oncology clinical trials, has announced the expansion of the company's relationship with START, a global Phase I oncology ...
read more
Mayne Pharma has entered into a binding agreement to acquire a portfolio of U.S. generic products from Teva and Allergan for cash consideration of $652 million. The portfolio consists of 37 approved products and 5 FDA filed products in attractive ...
read more
Catalent Pharma Solutions, has reached a commercial supply agreement with Palatin Technologies, Inc., to support the global commercial product launch of Palatin’s bremelanotide pen injector product, which is used to treat female sexual dysfunction (...
read more